Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
Authors
Keywords
-
Journal
BMC Nephrology
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-06-28
DOI
10.1186/1471-2369-13-49
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease
- (2011) Adriana S. Dusso et al. KIDNEY INTERNATIONAL
- The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder
- (2011) Eduardo Slatopolsky KIDNEY INTERNATIONAL
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor-23 in Early Chronic Kidney Disease: Additional Support in Favor of a Phosphate-Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism
- (2010) P. Evenepoel et al. Clinical Journal of the American Society of Nephrology
- Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
- (2010) T. Isakova et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
- (2009) Hirotaka Komaba et al. KIDNEY INTERNATIONAL
- Overview of the FGF23-Klotho axis
- (2009) Makoto Kuro-o PEDIATRIC NEPHROLOGY
- Novel Mechanisms in the Regulation of Phosphorus Homeostasis
- (2009) Theresa Berndt et al. PHYSIOLOGY
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
- (2008) Francesca Tentori et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
- (2008) T. Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
- (2008) F. Tentori et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular risk
- (2008) Vincenzo Savica et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started